Compounds > cyclopentane
Page last updated: 2024-08-21

cyclopentane and Cancer of Head

cyclopentane has been researched along with Cancer of Head in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, C; Jeong, LS; Jia, L; Kang, J; Li, L; Liang, Y; Liu, X; Liu, XK; Sun, S; Wang, X; Yan, Z; Yu, J; Zeng, MS; Zhang, W; Zhang, Y; Zhao, H; Zhong, Q1
Brands, RC; El-Mesery, M; Hartmann, S; Kübler, AC; Müller-Richter, UDA; Scheurer, MJJ; Seher, A1
Hassan, NM; Hu, GF; Ibaragi, S; Kishimoto, K; Mandai, H; Okui, T; Omori, K; Sasaki, A; Shibata, A; Shimo, T; Suga, S; Takashiba, S; Tsumura, T1
Khuri, FR; Lonial, S; Sun, SY; Yue, P; Zhao, L1
Andrews, NC; Aust, JB; Lawton, RL; Schroeder, JM1

Trials

1 trial(s) available for cyclopentane and Cancer of Head

ArticleYear
Clinical note. Phase II study of 1-aminocyclopentanecarboxylic acid (NSC-1026) in patients with cancer.
    Cancer chemotherapy reports, 1970, Volume: 54, Issue:4

    Topics: Amino Acids; Clinical Trials as Topic; Colonic Neoplasms; Cyclopentanes; Evaluation Studies as Topic; Feeding and Eating Disorders; Head and Neck Neoplasms; Humans; Leiomyosarcoma; Male; Neoplasms; Rectal Neoplasms; Sarcoma; Testicular Neoplasms; Valine; Vomiting

1970

Other Studies

4 other study(ies) available for cyclopentane and Cancer of Head

ArticleYear
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
    Cell proliferation, 2019, Volume: 52, Issue:2

    Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclopentanes; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; NEDD8 Protein; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyrimidines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck

2019
The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy.
    International journal of molecular sciences, 2019, Mar-15, Volume: 20, Issue:6

    Topics: Amides; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fas Ligand Protein; Head and Neck Neoplasms; Humans; Hydrocortisone; Interleukin-8; NF-kappa B; Phenyl Ethers; Pyrimidines; Quinazolines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Thiophenes; Tumor Necrosis Factor-alpha

2019
Synthetic Terrein Inhibits Progression of Head and Neck Cancer by Suppressing Angiogenin Production.
    Anticancer research, 2016, Volume: 36, Issue:5

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Disease Progression; Head and Neck Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Ribonuclease, Pancreatic

2016
The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cyclopentanes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Head and Neck Neoplasms; Humans; Proteolysis; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Ubiquitin-Activating Enzymes; Ubiquitination; Up-Regulation

2011